Literature DB >> 34524914

Infection of Glia by Human Pegivirus Suppresses Peroxisomal and Antiviral Signaling Pathways.

M A L Doan1, A Roczkowsky2, M Smith2, G Blevins2, F K H van Landeghem3, B B Gelman4, W G Branton2, J T Stapleton5,6, T C Hobman7, C Power1,2.   

Abstract

Human pegivirus (HPgV) infects peripheral leukocytes but was recently shown to be a neurotropic virus associated with leukoencephalitis in humans. In the present study, we investigated the neural cell tropism of HPgV as well as its effects on host immune responses. HPgV wild type (WT) and a mutant virus with a deletion in the HPgV NS2 gene (ΔNS2) were able to productively infect human astrocytes and microglia but not neurons or an oligodendrocyte-derived cell line. Of note, the ΔNS2 virus replicated better than WT pegivirus in astrocytes, with both viruses being able to subsequently infect and spread in fresh human astrocyte cultures. Infection of human glia by HPgV WT and ΔNS2 viruses resulted in suppression of peroxisome-associated genes, including PEX11B, ABCD1, PEX7, ABCD3, PEX3, and PEX5L, during peak viral production, which was accompanied by reduced expression of IFNB, IRF3, IRF1, and MAVS, particularly in ΔNS2-infected cells. These data were consistent with analyses of brain tissue from patients infected with HPgV in which we observed suppression of peroxisome and type I interferon gene transcripts, including PEX11B, ABCD3, IRF1, and IRF3, with concurrent loss of PMP70 immunoreactivity in glia. Our data indicate that human astrocytes and microglia are permissive to HPgV infection, resulting in peroxisome injury and suppressed antiviral signaling that is influenced by viral diversity. IMPORTANCE Human pegiviruses are detected in 1 to 5% of the general population, principally infecting leukocytes, although their effects on human health remain uncertain. Here, we show that human pegivirus infects specific neural cell types in culture and human brain and, like other neurotropic flaviviruses, causes suppression of peroxisome and antiviral signaling pathways, which could favor ongoing viral infection and perhaps confer susceptibility to the development of neurological disease.

Entities:  

Keywords:  glia; human pegivirus; peroxisome; type I interferon

Mesh:

Substances:

Year:  2021        PMID: 34524914      PMCID: PMC8577381          DOI: 10.1128/JVI.01074-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Lack of GB virus C/hepatitis G virus sequences in cerebrospinal fluid in patients with central nervous system infections.

Authors:  M Radkowski; W Przyjalkowski; D Lipowski; L F Wang; T Laskus
Journal:  Scand J Infect Dis       Date:  1998

2.  Human pegivirus-1 (HPgV-1) RNA prevalence and genotypes in volunteer blood donors from the Brazilian Amazon.

Authors:  S N Slavov; R Maraninchi Silveira; M R Hespanhol; V Sauvage; E S Rodrigues; L Fontanari Krause; H T Bittencourt; V Caro; S Laperche; D T Covas; S Kashima
Journal:  Transfus Clin Biol       Date:  2019-06-18       Impact factor: 1.406

3.  Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2013).

Authors:  M J Adams; A M Q King; E B Carstens
Journal:  Arch Virol       Date:  2013-04-12       Impact factor: 2.574

4.  Low level or absent in vivo replication of hepatitis C virus and hepatitis G virus/GB virus C in peripheral blood mononuclear cells.

Authors:  J Mellor; G Haydon; C Blair; W Livingstone; P Simmonds
Journal:  J Gen Virol       Date:  1998-04       Impact factor: 3.891

5.  Neurosteroid-mediated regulation of brain innate immunity in HIV/AIDS: DHEA-S suppresses neurovirulence.

Authors:  Ferdinand G Maingat; Maria J Polyak; Amber M Paul; Pornpun Vivithanaporn; Farshid Noorbakhsh; Samir Ahboucha; Glen B Baker; Keir Pearson; Christopher Power
Journal:  FASEB J       Date:  2012-11-12       Impact factor: 5.191

6.  Hepatitis C virus core protein induces neuroimmune activation and potentiates Human Immunodeficiency Virus-1 neurotoxicity.

Authors:  Pornpun Vivithanaporn; Ferdinand Maingat; Liang-Tzung Lin; Hong Na; Christopher D Richardson; Babita Agrawal; Eric A Cohen; Jack H Jhamandas; Christopher Power
Journal:  PLoS One       Date:  2010-09-21       Impact factor: 3.240

7.  Deep sequencing for the detection of virus-like sequences in the brains of patients with multiple sclerosis: detection of GBV-C in human brain.

Authors:  John D Kriesel; Maurine R Hobbs; Brandt B Jones; Brett Milash; Rashed M Nagra; Kael F Fischer
Journal:  PLoS One       Date:  2012-03-08       Impact factor: 3.240

8.  Hepatitis C virus NS3-4A inhibits the peroxisomal MAVS-dependent antiviral signalling response.

Authors:  Ana R Ferreira; Ana C Magalhães; Fátima Camões; Ana Gouveia; Marta Vieira; Jonathan C Kagan; Daniela Ribeiro
Journal:  J Cell Mol Med       Date:  2016-02-10       Impact factor: 5.310

9.  High HPgV replication is associated with improved surrogate markers of HIV progression.

Authors:  Gibran Horemheb-Rubio; Pilar Ramos-Cervantes; Hugo Arroyo-Figueroa; Santiago Ávila-Ríos; Claudia García-Morales; Gustavo Reyes-Terán; Galileo Escobedo; Gloria Estrada; Trinidad García-Iglesias; Nayeli Muñoz-Saucedo; David Kershenobich; Patricia Ostrosky-Wegman; Guillermo M Ruiz-Palacios
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

10.  Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis.

Authors:  Brienne A McKenzie; Manmeet K Mamik; Leina B Saito; Roobina Boghozian; Maria Chiara Monaco; Eugene O Major; Jian-Qiang Lu; William G Branton; Christopher Power
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-12       Impact factor: 11.205

View more
  3 in total

1.  Peroxisome injury in multiple sclerosis: protective effects of 4-phenylbutyrate in CNS-associated macrophages.

Authors:  Andrej Roczkowsky; Matthew A L Doan; Brittyne Hlavay; Manmeet K Mamik; William G Branton; Brienne A McKenzie; Leina B Saito; Laura Schmitt; Gary Eitzen; Francesca Di Cara; Melinda Wuest; Frank Wuest; Richard Rachubinski; Christopher Power
Journal:  J Neurosci       Date:  2022-08-08       Impact factor: 6.709

Review 2.  Human Pegivirus Type 1: A Common Human Virus That Is Beneficial in Immune-Mediated Disease?

Authors:  Jack T Stapleton
Journal:  Front Immunol       Date:  2022-05-30       Impact factor: 8.786

Review 3.  Review of human pegivirus: Prevalence, transmission, pathogenesis, and clinical implication.

Authors:  Yaqi Yu; Zhenzhou Wan; Jian-Hua Wang; Xianguang Yang; Chiyu Zhang
Journal:  Virulence       Date:  2022-12       Impact factor: 5.882

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.